Skip to main content
SpringerLink
Log in

Inhalation of insulin using the AERx insulin Diabetes Management System (iDMS) does not appear to be associated with lung cancer

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Aradigm Corporation.Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated with AERx(R) Insulin Diabetes Management System (iDMS). Media Release: 30 Apr 2008. Available from: URL: http://www.aradigm.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inhalation of insulin using the AERx insulin Diabetes Management System (iDMS) does not appear to be associated with lung cancer. React. Wkly. 1201, 3 (2008). https://doi.org/10.2165/00128415-200812010-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812010-00007

Keywords

Search

Navigation